Skip to main content
editorial
. 2020 May 22;25:45. doi: 10.4103/jrms.JRMS_331_20

Figure 1.

Figure 1

Schematic illustration depicting alveolar-capillary membrane changes in lung parenchyma in patients with COVID19 indicating a two-phase model theory addressing the proper timing of administering the two arms of treatment, antivirals and immunomodulators. Reconstructed with permission (Yufang Shi; doi: 10.1038/s41418-020-0530-3; March 26, 2020)